Supreme Court Rejects Plea Alleging Side Effects Of COVID-19 Vaccines

New Delhi:  The Supreme Court of India on Monday dismissed a petition alleging that COVID-19 vaccines caused severe side effects, including blood clotting, calling the plea as an attempt to create unnecessary alarm.

A bench led by Chief Justice DY Chandrachud, along with Justices JB Pardiwala and Manoj Misra, declined to entertain the petition, stating that it lacked merit. “We don’t want to rake this up. This is just to create a sensation,” remarked the bench, questioning the usefulness of the petition.

The court further highlighted the broader implications, suggesting that public health efforts might have been compromised if people had refrained from taking the vaccine.

During the proceedings, the court directly questioned the petitioner’s lawyer on whether he had taken the vaccine. After confirming that he had received the vaccine and experienced no side effects, the bench emphasized the lack of merit in the case.

The petition was filed by Priya Mishra and others, who sought to challenge the alleged adverse effects of the COVID-19 vaccination drive.

Case Details: PRIYA MISHRA AND ANR. vs UNION OF INDIA AND ORS., Diary No. 22945-2024

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16